Symyx Technologies Inc Sample Contracts

AMONG
Agreement and Plan of Merger • December 2nd, 2004 • Symyx Technologies Inc • Services-commercial physical & biological research • Oregon
AutoNDA by SimpleDocs
COMMON STOCK
Symyx Technologies Inc • September 21st, 1999 • New York
CREDIT AGREEMENT
Credit Agreement • October 4th, 2007 • Symyx Technologies Inc • Services-commercial physical & biological research • New York

THIS CREDIT AGREEMENT (“Agreement”) is entered into as of September 28, 2007, among SYMYX TECHNOLOGIES, INC., a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent and L/C Issuer.

LEASE
Lease • March 23rd, 2001 • Symyx Technologies Inc • Services-commercial physical & biological research
Exhibit 99.1 SYMYX TECHNOLOGIES, INC. STOCK OPTION ASSUMPTION AGREEMENT Dear Optionee: As you know, on November 30, 2004, (the "Closing Date") Symyx Technologies, Inc. ("Symyx") acquired IntelliChem, Inc. ("IntelliChem") through a merger transaction...
Stock Option Assumption Agreement • December 1st, 2004 • Symyx Technologies Inc • Services-commercial physical & biological research

As you know, on November 30, 2004, (the "Closing Date") Symyx Technologies, Inc. ("Symyx") acquired IntelliChem, Inc. ("IntelliChem") through a merger transaction (the "Merger") in accordance with the terms and conditions of that certain Agreement and Plan of Merger by and among Symyx, Orion Acquisition Corporation ("Orion"), and IntelliChem (the "Merger Agreement"). On the Closing Date, you held one or more outstanding unvested options to purchase shares of IntelliChem common stock granted to you under the IntelliChem 2003 Stock Option Plan, (the "Plan") and documented with a Stock Option Agreement (the "Option Agreement") issued to you under the Plan (the "IntelliChem Options"). In accordance with the Merger Agreement, on the Closing Date Symyx assumed all obligations of IntelliChem under the IntelliChem Options. This Agreement evidences the assumption of the IntelliChem Options, including the necessary adjustments to the unvested IntelliChem Options required by Section 2.2.2 of the

BACKGROUND
License and Supply Agreement • November 12th, 1999 • Symyx Technologies Inc • Services-commercial physical & biological research • California
BACKGROUND
License Agreement • August 8th, 2003 • Symyx Technologies Inc • Services-commercial physical & biological research • California
RECITALS
License Agreement • October 27th, 1999 • Symyx Technologies Inc • Services-commercial physical & biological research • California
CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS AGREEMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.]
And License Agreement • November 5th, 2003 • Symyx Technologies Inc • Services-commercial physical & biological research • New York
SYMYX TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreement • September 4th, 2007 • Symyx Technologies Inc • Services-commercial physical & biological research • Delaware

This Indemnification Agreement ("Agreement") is effective as of _____, 20__ by and between Symyx Technologies, Inc., a Delaware corporation (the "Company"), and ______ ("Indemnitee").

STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE MODIFIED NET
Symyx Technologies Inc • November 15th, 2005 • Services-commercial physical & biological research
BACKGROUND
Collaboration Agreement • November 17th, 1999 • Symyx Technologies Inc • Services-commercial physical & biological research • California
VOTING AGREEMENT
Voting Agreement • April 6th, 2010 • Symyx Technologies Inc • Services-prepackaged software • Delaware

This Voting Agreement (“Voting Agreement”) is entered into as of April 5, 2010, by and between Symyx Technologies, Inc., a Delaware corporation (“Symyx”), and _______ (“Stockholder”).

BACKGROUND
Celanese-Symyx Collaboration Agreement • November 17th, 1999 • Symyx Technologies Inc • Services-commercial physical & biological research • California
RECITALS
License Agreement • November 17th, 1999 • Symyx Technologies Inc • Services-commercial physical & biological research • California
AGREEMENT AND PLAN OF MERGER
Agreement and Plan of Merger • June 29th, 2010 • Symyx Technologies Inc • Services-prepackaged software • Delaware
GUARANTEE
Guarantee • June 29th, 2010 • Symyx Technologies Inc • Services-prepackaged software

GUARANTEE, dated as of June 28, 2010 (this “Guarantee”), by Vector Capital III, L.P. and Vector Capital IV, L.P. (collectively, the “Guarantors”, and each, a “Guarantor”), in favor of Symyx Technologies, Inc., a Delaware corporation (the “Guaranteed Party”).

AutoNDA by SimpleDocs
ASSET PURCHASE AGREEMENT among: HPR Global, Inc., a Delaware corporation, Symyx Technologies, Inc., a Delaware corporation and Symyx Solutions, Inc., an Oregon corporation Dated as of February 11, 2010
Asset Purchase Agreement • February 26th, 2010 • Symyx Technologies Inc • Services-prepackaged software • California

This Asset Purchase Agreement is entered into as of February 11, 2010, by and among HPR Global, Inc., a Delaware corporation (“Purchaser”), Symyx Technologies, Inc., a Delaware corporation (“Parent”) and Symyx Solutions, Inc., an Oregon corporation and wholly-owned subsidiary of Parent (“Seller”). Certain capitalized terms used in this Agreement are defined in Exhibit A.

Alliance, Technology Transfer, Research and License Agreement The Dow Chemical Company - Symyx Technologies, Inc. – Symyx Discovery Tools, Inc.
License Agreement • March 8th, 2005 • Symyx Technologies Inc • Services-commercial physical & biological research • Delaware

This ALLIANCE, TECHNOLOGY TRANSFER, RESEARCH AND LICENSE AGREEMENT (the “Agreement”), effective as of January 1, 2005 (the “Effective Date”), is made by and between Symyx Technologies, Inc., a Delaware corporation having a principal place of business at 3100 Central Expressway, Santa Clara, California 95051 (“Symyx Tech”), Symyx Discovery Tools, Inc., a California corporation having a principal place of business at 3100 Central Expressway, Santa Clara, California 95051 (“Symyx Dtools”) (Symyx Tech and Symyx Dtools referred to collectively as “Symyx”) and The Dow Chemical Company, a Delaware corporation, having a principal place of business at 2030 Willard H. Dow Center, Midland, Michigan 48674 (“TDCC”).

BACKGROUND
Research and License Agreement • November 17th, 1999 • Symyx Technologies Inc • Services-commercial physical & biological research • Delaware
RESEARCH AND LICENSE AGREEMENT Effective January 1, 2008 among Symyx Technologies, Inc. Symyx Tools, Inc. Symyx Software, Inc. and ExxonMobil Research and Engineering Company ExxonMobil Chemical Company
Research and License Agreement • March 13th, 2009 • Symyx Technologies Inc • Services-prepackaged software • New York

This Research and License Agreement (“Agreement”), effective as of January 1, 2008 (“Effective Date”), is entered into by and among ExxonMobil Research and Engineering Company (“EMRE”); ExxonMobil Chemical Company (“EMCC”) (collectively, “ExxonMobil”), and Symyx Technologies, Inc. (“Symyx Tech”) Symyx Tools, Inc. (“Symyx Tools”) and Symyx Software, Inc. (“Symyx Software”) (collectively, “Symyx”). Certain definitions are set forth in Exhibit A hereto.

SYMYX TECHNOLOGIES, INC. OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION)
Option Agreement • November 8th, 2007 • Symyx Technologies Inc • Services-commercial physical & biological research

Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, Symyx Technologies, Inc. (the “Company”) has granted you an option under its 2007 Stock Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Option Agreement but defined in the Plan shall have the same definitions as in the Plan.

SYMYX TECHNOLOGIES, INC. OPTION AGREEMENT (NONSTATUTORY STOCK OPTION)
Option Agreement • November 9th, 2007 • Symyx Technologies Inc • Services-commercial physical & biological research

Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, Symyx Technologies, Inc. (the “Company”) has granted you an option under its 2001 Nonstatutory Stock Option Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Option Agreement but defined in the Plan shall have the same definitions as in the Plan.

SALE AGREEMENT by and among ELSEVIER INC., ELSEVIER SWISS HOLDINGS S.A., ELSEVIER JAPAN KK, ELSEVIER LIMITED and MDL INFORMATION SYSTEMS (UK) LIMITED, as SELLERS, and SYMYX TECHNOLOGIES, INC., as BUYER August 9, 2007
Sale Agreement • August 15th, 2007 • Symyx Technologies Inc • Services-commercial physical & biological research • New York

SALE AGREEMENT, dated as of August 9, 2007 (the “Agreement”), by and among Elsevier Inc., a New York corporation (“Elsevier Inc.”), Elsevier Swiss Holdings S.A., a company organized under the laws of Switzerland (“Elsevier S.A.”), Elsevier Japan KK, a company organized under the laws of Japan (“Elsevier KK”), Elsevier Limited, a company organized under the laws of England and Wales (“Elsevier UK”), MDL Information Systems (UK) Limited, a company organized under the laws of England and Wales (“MDL (UK) Limited”) (Elsevier Inc., Elsevier S.A., Elsevier KK, Elsevier UK and MDL (UK) Limited are sometimes referred to individually as a “Seller” and collectively as the “Sellers”) and Symyx Technologies, Inc., a Delaware corporation (“Buyer”).

SUPPLEMENTAL AGREEMENT
Supplemental Agreement • March 17th, 2008 • Symyx Technologies Inc • Services-commercial physical & biological research
RECITALS
Investor Rights Agreement • September 21st, 1999 • Symyx Technologies Inc • California
October 1, 2007 Trevor Heritage Dear Trevor,
Symyx Technologies Inc • May 8th, 2009 • Services-prepackaged software
THIRD AMENDMENT TO CREDIT AGREEMENT
Credit Agreement • November 5th, 2009 • Symyx Technologies Inc • Services-prepackaged software

This THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of September 25, 2009, among SYMYX TECHNOLOGIES, INC., a Delaware corporation (the “Borrower”), each lender from time to time party thereto (collectively, the “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent (the “Administrative Agent”) and as L/C Issuer.

SYMYX TECHNOLOGIES, INC. STOCK OPTION ASSUMPTION AGREEMENT
Stock Option Assumption Agreement • April 4th, 2005 • Symyx Technologies Inc • Services-commercial physical & biological research

As you know, on April 1, 2005, (the “Closing Date”) Symyx Technologies, Inc. (“Symyx”) acquired Synthematix, Inc. (“Synthematix”) through a merger transaction (the “Merger”) in accordance with the terms and conditions of that certain Agreement and Plan of Merger by and among Symyx, Tar Acquisition Corporation (“Tar”), Synthematix and Clay Thorpe, as representative (the “Merger Agreement”). On the Closing Date, you held one or more outstanding unvested options to purchase shares of Synthematix common stock granted to you under the Synthematix Equity Compensation Plan, as amended, (the “Plan”) and documented with a Stock Option Agreement (the “Option Agreement”) issued to you under the Plan (the “Synthematix Options”). In accordance with the Merger Agreement, on the Closing Date Symyx assumed all obligations of Synthematix under the Synthematix Options. This Agreement evidences the assumption of the Synthematix Options, including the necessary adjustments to the unvested Synthematix Opti

Time is Money Join Law Insider Premium to draft better contracts faster.